DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Mabuchi S, Altomare DA, Connolly DC, Klein-Szanto A, Litwin S, Hoelzle MK, Hensley HH, Hamilton TC, Testa JR.
RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer.
Cancer Res 2007; 67: 2408-2413
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.